Evaluation of systemic microvascular reactivity in adults with congenital heart disease

Pablo Marino1,2, Gabriella de Oliveira Lopes1,3, Juliana Pereira Borges3

  • 1National Institute of Cardiology, Rio de Janeiro, Brazil.

Congenital Heart Disease
|September 12, 2018
PubMed

Insights

Adults with congenital heart disease show higher baseline microvascular blood flow but no endothelial dysfunction. However, impaired endothelium-independent reactivity suggests vascular smooth muscle or structural changes, particularly in those with lower functional capacity.

Area of Science:

  • Cardiovascular Research
  • Microcirculation Physiology
  • Adult Congenital Heart Disease

Background:

  • Adults with congenital heart disease (ACHD) share similarities with chronic heart failure patients.
  • Microvascular endothelial dysfunction is known in heart failure, but unstudied in ACHD.
  • Systemic microvascular reactivity in ACHD requires investigation.

Purpose of the Study:

  • To investigate systemic microvascular reactivity in adults with congenital heart disease.
  • To compare microvascular function between ACHD patients and healthy controls.

Main Methods:

  • Cardiopulmonary exercise testing was performed on ACHD patients.
  • Cutaneous microvascular reactivity assessed using laser speckle contrast imaging.
  • Iontophoresis of acetylcholine and sodium nitroprusside, plus postocclusive reactive hyperemia (PORH), evaluated endothelial-dependent and -independent responses.

Main Results:

  • ACHD patients exhibited higher basal microvascular flow and acetylcholine response compared to controls.
  • Endothelium-independent vasodilation to sodium nitroprusside was reduced in ACHD patients.
  • No significant difference in PORH response was observed between groups.
  • Lower functional capacity in ACHD patients correlated with higher basal microvascular flow.

Conclusions:

  • ACHD patients have elevated baseline cutaneous microvascular blood flow but lack systemic endothelial dysfunction.
  • Blunted endothelium-independent microvascular reactivity in ACHD suggests vascular smooth muscle or structural alterations.
  • Reduced functional capacity in ACHD is associated with increased basal microvascular flow.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
359
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
315
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
338
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
542
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
480
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.0K